Prosecution Insights
Last updated: May 29, 2026
Application No. 17/933,684

CONTINUOUS GLUCOSE MONITORING DEVICE

Final Rejection §103
Filed
Sep 20, 2022
Priority
Apr 06, 2018 — provisional 62/653,821 +1 more
Examiner
JANG, CHRISTIAN Y
Art Unit
3791
Tech Center
3700 — Mechanical Engineering & Manufacturing
Assignee
Allez Health Inc.
OA Round
2 (Final)
69%
Grant Probability
Favorable
3-4
OA Rounds
1m
Est. Remaining
89%
With Interview

Examiner Intelligence

Grants 69% — above average
69%
Career Allowance Rate
578 granted / 842 resolved
-1.4% vs TC avg
Strong +21% interview lift
Without
With
+20.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 9m
Avg Prosecution
26 currently pending
Career history
869
Total Applications
across all art units

Statute-Specific Performance

§101
9.7%
-30.3% vs TC avg
§103
63.7%
+23.7% vs TC avg
§102
6.1%
-33.9% vs TC avg
§112
15.0%
-25.0% vs TC avg
Black line = Tech Center average estimate • Based on career data from 842 resolved cases

Office Action

§103
DETAILED ACTION Terminal Disclaimer The terminal disclaimer filed on 12/8/25 disclaiming the terminal portion of any patent granted on this application which would extend beyond the expiration date of USP #11,478,174 has been reviewed and is accepted. The terminal disclaimer has been recorded. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. Claim(s) 1-18 is/are rejected under 35 U.S.C. 103 as being unpatentable over Brister et al. (US 2007/0027385) in view of Knopefmacher et al. (US 2017/0342459). As to claim 1, Brister teaches a wire-based ([0269]) three-pole electrochemical sensor ([0272]) for subcutaneous insertion ([0392]) comprising: a working electrode comprising a first split wire (Fig. 7M – E1) having a first flat surface along a length of the first split wire (Fig. 7M), the first flat surface created from a first full wire having a circular cross-section with a portion removed ([0345]); a reference electrode comprising a second split wire having a second flat surface along a length of the second split wire (Fig. 7M – R1), the second flat surface created from a full wire defined by a chord across a circular cross-section of the split wire (Fig. 7M), and a counter electrode ([0345] – at least one of the working electrodes is a counter electrode, E2) comprising a third split wire having a third flat surface along a length of the third split wire, the third flat surface created from a wire defined by a third chord across a circular cross-section of the split wire (Fig. 7M); wherein the second and third flat surface face toward one another (Fig. 7M – right side of R1 and left side of E2); wherein a cross-sectional diameter of the first split wire, the second split wire, and the third split wire coupled together is less than an inner diameter of an insertion needle ([0310] – inherent as the needle is able to insert the sensor and subsequently slide back over the sensor and release the sensor from the needle, something that can only be achieved if the electrodes, coupled together, is smaller than the diameter of the insertion needle). Brister does not necessarily teach that the three electrodes are all created from their own “full wires” or a support sheet on the first flat surface. However, it would have been obvious, if not necessarily inherent, to create individual electrodes from their own wire for various reasons including ease of manufacture. Knopfmacher teaches an electrode in which a conductor layer is laid on the substrate, said conductor layer comprising combinations of carbon nanotude, graphene, and polyaniline ([0068]). As such, it would have been obvious to modify Brister further with Knopfmacher to utilize materials that is known to serve well as materials for an electrochemical sensor. As to claims 2, 3, and 12, Knopfmacher teaches the support sheet comprises carbon, graphene, or polyaniline ([0068]). As to claims 4 and 13, Knopfmacher teaches the support sheet is electrically conductive (210) and coupled to a flat surface of a substrate (Fig. 2B – 212), which in combination with Brister, would result in being electrically coupled to the first surface of the first split wire. As to claims 5 and 11, Brister teaches a sensing chemistry deposited on the electrode (electrode domain 24) on the electroactive surface, which in combination with Knopfmacher would result in its deposition on the support sheet ([0278]). As to claims 6 and 14, Brister teaches a polymer layer over the support sheet (Fig. 2A – any of 24, 26, 28, and 30) which in combination with Knopfmacher would result in its deposition on the support sheet ([0278-0310]). As to claims 7-8 and 15-16, Brister does not explicitly teach the specific cross-section shapes recited for the various electrodes in the above embodiment. However, Brister teaches numerous configurations of electrodes, including those that have a semicircular cross-section (Fig. 7F) as well as those with a rectangular cross-section (Fig. 7G). It would have been obvious for one of ordinary skill in the art to mix and match the various shapes as they are all taught and such a modification would be obvious to try. As to claims 9-10 and 17-18, Brister does not explicitly teach the specific percentage and range of percentages recited for the surface area and the cross-section area. However, Brister teaches an electrode structure in which various electrodes are shaped in such a way relative to a wire electrode that the split wires can have the percentages recited (Fig. 7M). It would be a mere matter of routine optimization to derive at the specific numbers being recited, as there is no disclosed criticality to the recited numbers. Response to Arguments Applicant's arguments filed 12/8/25 have been fully considered but they are not persuasive. Applicant has argued that neither reference individually teaches “a support sheet on the first flat surface”. In particular, applicant has argued that Knopfmacher teaches a conductor layer on a nonconductive substrate to render the substrate conductive for planar sensor operation, not to interface with a wire electrode. In contrast, applicant argues that the support sheet of the present claims is electrically coupled to the wire and conducts signals from the sensing chemistry into the wire, forming part of the electrochemical circuit for in vivo monitoring. However, examiner notes that the claim 1 merely recites “a support sheet on the first flat surface”, and does not recite any of the functionality that the applicant asserts. In response to applicant's arguments against the references individually, one cannot show nonobviousness by attacking references individually where the rejections are based on combinations of references. See In re Keller, 642 F.2d 413, 208 USPQ 871 (CCPA 1981); In re Merck & Co., 800 F.2d 1091, 231 USPQ 375 (Fed. Cir. 1986). In response to applicant's argument that the examiner's conclusion of obviousness is based upon improper hindsight reasoning, it must be recognized that any judgment on obviousness is in a sense necessarily a reconstruction based upon hindsight reasoning. But so long as it takes into account only knowledge which was within the level of ordinary skill at the time the claimed invention was made, and does not include knowledge gleaned only from the applicant's disclosure, such a reconstruction is proper. See In re McLaughlin, 443 F.2d 1392, 170 USPQ 209 (CCPA 1971). Applicant has also argued that Knopfmacher is non-analogous art, as it is primarily directed to planar, in vitro electrochemical sensing. However, the only aspect of Knopfmacher that is being incorporated is its teaching of a “support sheet on a flat surface”, and one of ordinary skill in the art would be readily capable of applying its teachings to an in vivo implantable device. Moreover, while applicant repeatedly emphasizes that Knopfmacher’s teaching is “optimized for planar surfaces” and that it does not “contemplate adapting carbon-based sheets to curved wire surfaces for subcutaneous insertion”, the examiner notes that the support sheet, as recited, is applied to a “flat surface” (i.e. planar) and not directly to any “curved wire surfaces”. Finally, the applicant argues that the recited invention delivers results that could not have been predicted by the teachings of Brister and Knopfmacher as it enables a three-pole sensor that fits within the space traditionally occupied by two wires. The examiner again notes that such a feature is not recited in the claims. Moreover, the primary embodiment applied in the rejection, as taught by Brister (Fig. 7M), actually allows for 5 separate electrodes within the space that would otherwise be occupied by a single wire, making this argument similarly unpersuasive. Lastly, the examiner notes that even if the claim recited a support “sheet” on a curved wire surface, such a feature would not be considered novel or non-obvious. Feldman et al. (US 2014/0171771) teaches an implantable dermal glucose sensor (Abstract, [0049], [0067]) in which a working electrode is formed by first coating a conductive layer such as silver on a non-planar substrate, and additional “support layers” such as a carbon layer can be disposed on top of this first conductive layer, and then be further covered with a membrane including sensing chemistry ([0055]). It teaches that this additional layer serves as a support layer in enhancing electrode conductivity and/or adhesion of any additional layers, such as the sensing chemistry layer ([0053]). Conclusion THIS ACTION IS MADE FINAL. Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. The prior art made of record and not relied upon is considered pertinent to applicant's disclosure. Feldman et al. (US 2014/0171771). See above for details. Any inquiry concerning this communication or earlier communications from the examiner should be directed to CHRISTIAN JANG whose telephone number is (571)270-3820. The examiner can normally be reached Monday-Friday (7-3:30 EST). Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Robert Chen can be reached at 571-272-3672. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. CHRISTIAN JANG Primary Examiner Art Unit 3791 /CHRISTIAN JANG/Primary Examiner, Art Unit 3791 12/17/25
Read full office action

Prosecution Timeline

Sep 20, 2022
Application Filed
Sep 11, 2025
Non-Final Rejection mailed — §103
Dec 08, 2025
Response Filed
Dec 22, 2025
Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12635913
GUARD RINGS FOR ON-BODY ANALYTE SENSORS
4y 2m to grant Granted May 26, 2026
Patent 12623020
ANALYTE DETECTION SYSTEM AND CONTINUOUS GLUCOSE MONITORING DEVICE
3y 0m to grant Granted May 12, 2026
Patent 12616396
ANALYTE SENSOR DEVICES, CONNECTIONS, AND METHODS
4y 5m to grant Granted May 05, 2026
Patent 12616397
ANALYTE SENSOR DEVICES, CONNECTIONS, AND METHODS
4y 1m to grant Granted May 05, 2026
Patent 12605092
INTERCONNECT FOR ON-BODY ANALYTE MONITORING DEVICE
4y 3m to grant Granted Apr 21, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

3-4
Expected OA Rounds
69%
Grant Probability
89%
With Interview (+20.7%)
3y 9m (~1m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 842 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month